Successful treatment of invasive carbapenemase-producing Enterobacteriaceae infections in children using carbapenem-aminoglycoside combination therapy: A case series

Infect Dis Health. 2020 Nov;25(4):314-318. doi: 10.1016/j.idh.2020.06.002. Epub 2020 Jul 19.

Abstract

Multidrug-resistant infections present a treatment challenge for pediatric clinicians and these infections have been associated with increased morbidity and mortality. There are very limited published data to support safe and effective treatment regimens for carbapenemase-producing Enterobacteriaceae (CPE) infections, particularly in children. We report the successful treatment of three children with invasive CPE infections using a combination of extended-infusion meropenem and amikacin.

Keywords: AMR; Antimicrobial resistance; CPE; CRE; Multi-resistant organisms; Pediatrics.

Publication types

  • Case Reports

MeSH terms

  • Aminoglycosides / administration & dosage
  • Aminoglycosides / pharmacology
  • Aminoglycosides / therapeutic use*
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use*
  • Carbapenem-Resistant Enterobacteriaceae / drug effects
  • Carbapenem-Resistant Enterobacteriaceae / isolation & purification*
  • Carbapenems / administration & dosage
  • Carbapenems / pharmacology
  • Carbapenems / therapeutic use*
  • Child
  • Enterobacteriaceae Infections / drug therapy*
  • Female
  • Humans
  • Infant
  • Male
  • Microbial Sensitivity Tests

Substances

  • Aminoglycosides
  • Anti-Bacterial Agents
  • Carbapenems